Literature DB >> 20586642

Pancreatic manifestations of von Hippel-Lindau disease.

Anthony-Osei F Safo1, Stefan E Pambuccian.   

Abstract

Von Hippel-Lindau disease is an uncommon, multisystem, multitumor disorder that can present in sporadic form but is more commonly inherited as an autosomal-dominant disease with high penetrance. Affected patients are at increased risk for developing multiple synchronous or metachronous benign or malignant, cystic, and vascular neoplasms of various organs. The characteristic neoplasms associated with von Hippel-Lindau are hemangioblastoma of the central nervous system and retina, clear cell renal cell carcinoma, and pheochromocytoma, but other lesions are well recognized. Pancreatic lesions, both primary and metastatic, are common, and several differential diagnostic possibilities must be considered.

Entities:  

Mesh:

Year:  2010        PMID: 20586642     DOI: 10.5858/2009-0172-RS.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  9 in total

Review 1.  Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature.

Authors:  Michael Charlesworth; Caroline S Verbeke; Gavin A Falk; Matthew Walsh; Andrew M Smith; Gareth Morris-Stiff
Journal:  J Gastrointest Surg       Date:  2012-02-28       Impact factor: 3.452

2.  Role of cortical sparing adrenalectomy and novel variant of mutation in patient with von Hippel-Lindau disease.

Authors:  Ranil Johann Boaz; Pooja Ramakant; Andrew Ebenazer; Rekha Pai; Simon Rajaratnam; Deepak Abraham; M J Paul
Journal:  Indian J Endocrinol Metab       Date:  2011-10

3.  Pancreatic insufficiency following pancreatectomy: Does underlying tumor syndrome confer a greater risk?

Authors:  James D McDonald; Shreya Gupta; Mackenzie L Shindorf; Amy Copeland; Meghan L Good; Samira M Sadowski; Naris Nilubol
Journal:  Am J Surg       Date:  2020-09-05       Impact factor: 3.125

4.  Von Hippel-Lindau Disease With Multi-Organ Involvement: A Case Report and 8-Year Clinical Course With Follow-Up.

Authors:  Ali Yaghobi Joybari; Payam Azadeh
Journal:  Am J Case Rep       Date:  2017-11-17

5.  Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma.

Authors:  Kenan Ashouri; Sophia Mohseni; John Tourtelot; Pranav Sharma; Philippe E Spiess
Journal:  J Kidney Cancer VHL       Date:  2015-09-25

Review 6.  When should genetic testing be performed in patients with neuroendocrine tumours?

Authors:  Triona O'Shea; Maralyn Druce
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

7.  Von hippel-lindau disease: a new approach to an old problem.

Authors:  Ali Tootee; Shirin Hasani-Ranjbar
Journal:  Int J Endocrinol Metab       Date:  2012-09-30

Review 8.  Management Strategies and Outcomes for VHL-related Craniospinal Hemangioblastomas.

Authors:  Christ Ordookhanian; Paul E Kaloostian; Samer S Ghostine; Philippe E Spiess; Arnold B Etame
Journal:  J Kidney Cancer VHL       Date:  2017-08-28

9.  Stabilization of HIF-2α impacts pancreas growth.

Authors:  Alvaro Flores-Martínez; Alejandro García-Núñez; Anabel Rojas; David A Cano
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.